Gabelli Healthcare & WellnessRx Trust (NYSE: GRX) Increases Quarterly Distribution 13% to $0.17 From $0.15 Annual Distribution to $0.68 From $0.60 Per Share
Gabelli Healthcare & WellnessRx Trust (NYSE: GRX) Increases Quarterly Distribution 13% to $0.17 From $0.15 Annual Distribution to $0.68 From $0.60 Per Share
The Gabelli Healthcare & WellnessRx Trust (GRX) announced a 13% increase in its quarterly distribution from $0.15 to $0.17 per share, raising the annual distribution from $0.60 to $0.68 per share. The increased quarterly distribution will be paid on June 23, 2025, to shareholders of record as of June 13, 2025. Based on current accounting records, the 2025 distributions comprise approximately 4% from net investment income, 80% from net capital gains, and 16% return of capital. The Fund's Board of Trustees regularly reviews distribution levels, considering net asset value and market conditions, with the policy subject to modification or termination at any time.
Il Gabelli Healthcare & WellnessRx Trust (GRX) ha annunciato un aumento del 13% nella sua distribuzione trimestrale, passando da $0,15 a $0,17 per azione, incrementando la distribuzione annuale da $0,60 a $0,68 per azione. La distribuzione trimestrale aumentata sarà pagata il 23 giugno 2025 agli azionisti registrati al 13 giugno 2025. Secondo i dati contabili attuali, le distribuzioni del 2025 comprendono circa il 4% da reddito netto da investimenti, l'80% da plusvalenze nette e il 16% come ritorno di capitale. Il Consiglio di Amministrazione del Fondo esamina regolarmente i livelli di distribuzione, considerando il valore patrimoniale netto e le condizioni di mercato, con la politica soggetta a modifiche o cessazioni in qualsiasi momento.
El Gabelli Healthcare & WellnessRx Trust (GRX) anunció un aumento del 13% en su distribución trimestral, pasando de $0.15 a $0.17 por acción, elevando la distribución anual de $0.60 a $0.68 por acción. La distribución trimestral incrementada se pagará el 23 de junio de 2025 a los accionistas registrados al 13 de junio de 2025. Según los registros contables actuales, las distribuciones de 2025 comprenden aproximadamente un 4% de ingresos netos por inversiones, 80% de ganancias netas de capital y 16% de retorno de capital. La Junta de Fiduciarios del Fondo revisa regularmente los niveles de distribución, considerando el valor neto de los activos y las condiciones del mercado, con la política sujeta a modificaciones o terminaciones en cualquier momento.
Gabelli Healthcare & WellnessRx Trust (GRX)는 분기 배당금을 기존 주당 $0.15에서 13% 인상된 $0.17로 올렸으며, 연간 배당금도 주당 $0.60에서 $0.68로 증가했다고 발표했습니다. 증가된 분기 배당금은 2025년 6월 23일에 2025년 6월 13일 기준 주주에게 지급됩니다. 현재 회계 기록에 따르면 2025년 배당금은 약 4%가 순투자수익, 80%가 순자본이익, 16%가 자본환원으로 구성됩니다. 펀드 이사회는 순자산 가치와 시장 상황을 고려하여 배당 수준을 정기적으로 검토하며, 정책은 언제든지 변경되거나 종료될 수 있습니다.
Le Gabelli Healthcare & WellnessRx Trust (GRX) a annoncé une augmentation de 13 % de sa distribution trimestrielle, passant de 0,15 $ à 0,17 $ par action, portant la distribution annuelle de 0,60 $ à 0,68 $ par action. La distribution trimestrielle augmentée sera versée le 23 juin 2025 aux actionnaires inscrits au 13 juin 2025. Selon les registres comptables actuels, les distributions de 2025 se composent d'environ 4 % de revenus nets d'investissement, 80 % de gains nets en capital et 16 % de retour de capital. Le conseil d'administration du Fonds examine régulièrement les niveaux de distribution en tenant compte de la valeur nette d'inventaire et des conditions du marché, la politique pouvant être modifiée ou interrompue à tout moment.
Der Gabelli Healthcare & WellnessRx Trust (GRX) gab eine 13%ige Erhöhung seiner vierteljährlichen Ausschüttung von $0,15 auf $0,17 pro Aktie bekannt und erhöhte damit die jährliche Ausschüttung von $0,60 auf $0,68 pro Aktie. Die erhöhte vierteljährliche Ausschüttung wird am 23. Juni 2025 an die zum 13. Juni 2025 eingetragenen Aktionäre ausgezahlt. Basierend auf den aktuellen Buchhaltungsunterlagen setzen sich die Ausschüttungen 2025 ungefähr aus 4% aus Nettoanlageerträgen, 80% aus Nettokapitalgewinnen und 16% Kapitalrückzahlung zusammen. Der Vorstand des Fonds überprüft regelmäßig die Ausschüttungsniveaus unter Berücksichtigung des Nettoinventarwerts und der Marktbedingungen; die Richtlinie kann jederzeit geändert oder eingestellt werden.
Positive
13% increase in quarterly distribution from $0.15 to $0.17 per share
Annual distribution raised to $0.68 from $0.60 per share
80% of distributions come from net capital gains, indicating strong portfolio performance
Negative
16% of distributions classified as return of capital, which reduces shareholder cost basis
Only 4% of distributions come from net investment income, suggesting low dividend yield from portfolio holdings
Insights
GRX's 13% distribution increase signals strong fund performance and enhances shareholder returns, though partially funded through capital gains and return of capital.
The 13% increase in GRX's quarterly distribution from $0.15 to $0.17 per share represents significant positive news for income-focused investors. This boost brings the annualized distribution to $0.68 from the previous $0.60 per share, enhancing the fund's income appeal.
Looking at the distribution composition is particularly revealing: only 4% comes from net investment income, while 80% derives from net capital gains and 16% constitutes return of capital. This structure indicates that GRX's distribution is primarily supported by realized gains rather than dividend and interest income from underlying holdings.
The substantial capital gains component suggests the fund's portfolio managers have successfully captured profits from healthcare and wellness investments. However, the 16% return of capital portion means a fraction of distributions represents shareholders receiving back part of their original investment rather than new earnings.
The distribution policy review by the Board each quarter creates a governance mechanism to adjust payouts based on fund performance, asset values, and market conditions. This flexible approach allows them to maintain competitive distributions while responding to changing investment environments.
For taxable investors, the composition provides favorable tax treatment since long-term capital gains and qualified dividends typically face lower tax rates than ordinary income, though some shareholders may face the additional 3.8% Medicare surcharge on investment income.
RYE, N.Y., May 14, 2025 (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (the “Fund”) approved an increase in the annualized distribution to $0.68 per share, which will be paid $0.17 per share quarterly, commencing with the quarterly distribution payable on June 23, 2025 to common shareholders of record on June 13, 2025.
The Fund intends to pay a quarterly distribution determined by the Board of Trustees. In addition to the quarterly distributions, and in accordance with the minimum distribution requirements of the Internal Revenue Code for regulated investment companies, the Fund may pay an adjusting distribution in December which includes any additional income and net realized capital gains in excess of the quarterly distributions for that year.
Each quarter, the Board of Trustees reviews the amount of any potential distribution and the income, realized capital gain, or capital available. The Board of Trustees will continue to monitor the Fund’s distribution level, taking into consideration the Fund’s net asset value and the current financial market environment. The Fund’s distribution policy is subject to modification or termination by the Board of Trustees at any time, and there can be no guarantee that the policy will continue. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund.
All or part of the distribution may be treated as long-term capital gain or qualified dividend income (or a combination of both) for individuals, each subject up to the maximum federal income tax rate for long term capital gains, which is currently 20% in taxable accounts for individuals (or less depending on an individual’s tax bracket). In addition, certain U.S. shareholders who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare surcharge on their "net investment income", which includes dividends received from the Fund and capital gains from the sale or other disposition of shares of the Fund.
If the Fund does not generate earnings (dividends and interest income, less expenses, and realized net capital gain) equal to or in excess of the aggregate distributions paid by the Fund in a given year, then the amount distributed in excess of the Fund’s earnings would be deemed a return of capital. Since this would be considered a return of a portion of a shareholder’s original investment, it is generally not taxable and would be treated as a reduction in the shareholder’s cost basis.
Long-term capital gains, qualified dividend income, investment company taxable income, and return of capital, if any, will be allocated on a pro rata basis to all distributions to common shareholders for the year. Based on the accounting records of the Fund currently available, each of the distributions paid to common shareholders in 2025 would include approximately 4% from net investment income, 80% from net capital gains and 16% would be deemed a return of capital on a book basis. This does not represent information for tax reporting purposes. The estimated components of each distribution are updated and provided to shareholders of record in a notice accompanying the distribution and are available on our website (www.gabelli.com). The final determination of the sources of all distributions in 2025 will be made after year end and can vary from the quarterly estimates. Shareholders should not draw any conclusions about the Fund’s investment performance from the amount of the current distribution. All individual shareholders with taxable accounts will receive written notification regarding the components and tax treatment for all 2025 distributions in early 2026 via Form 1099-DIV.
Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing. For more information regarding the Fund’s distribution policy and other information about the Fund, call:
Bethany Uhlein (914) 921-5546
About The Gabelli Healthcare & WellnessRx Trust The Gabelli Healthcare & WellnessRx Trust is a diversified, closed-end management investment company with $218 million in total net assets whose primary investment objective is long-term growth of capital. The Fund is managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc. (OTCQX: GAMI).
What is the new quarterly distribution amount for Gabelli Healthcare & WellnessRx Trust (GRX)?
The new quarterly distribution amount for GRX is $0.17 per share, increased from $0.15, representing a 13% increase.
When will GRX's increased quarterly distribution be paid?
The increased quarterly distribution will be paid on June 23, 2025, to shareholders of record as of June 13, 2025.
What is the composition of GRX's 2025 distributions?
Based on current accounting records, GRX's 2025 distributions comprise 4% from net investment income, 80% from net capital gains, and 16% return of capital.
What is the new annual distribution rate for GRX stock?
The new annual distribution rate for GRX stock is $0.68 per share, increased from $0.60 per share.
Are GRX's distributions guaranteed to continue at the new rate?
No, the Fund's distribution policy is subject to modification or termination by the Board of Trustees at any time, with no guarantee of continuation.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
